Four Decades for Justice
Cravath represented the underwriters, Goldman, Sachs & Co. and J.P. Morgan Securities, in connection with the US$965 million registered secondary common stock offering of Zimmer Biomet Holdings, Inc., a global leader in musculoskeletal healthcare. The shares were listed on the New York Stock Exchange. The transaction closed on August 12, 2016.
The Cravath team included partners William J. Whelan III and William V. Fogg and associates Lee M. Blum, Martin P. Pepeljugoski and Alan Campbell.
Deals & Cases
December 15, 2023
Cravath represented the underwriters in connection with the $500 million registered notes offering of Zimmer Biomet Holdings, Inc., a global leader in musculoskeletal healthcare. The transaction closed on December 1, 2023.
Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.
Attorney Advertising. ©2024 Cravath, Swaine & Moore LLP.